Infliximab [[electronic resource] ] : pharmacology, uses and limitations / / Antonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors |
Edizione | [1st ed.] |
Pubbl/distr/stampa | New York, : Nova Science Publishers, c2012 |
Descrizione fisica | 1 online resource (204 p.) |
Disciplina | 615.7/94 |
Altri autori (Persone) |
Fajardo GaitanMontserrat
Medrano AcevedoAntonio D |
Collana | Immunology and immune system disorders |
Soggetto topico |
Anti-inflammatory agents
Infliximab - Therapeutic use Infliximab |
ISBN | 1-61942-345-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""Contents ""; ""Preface ""; ""The Risk of Infection in Patients Treated with Infliximab ""; ""Abstract ""; ""1. Definition and Functions of Tumour Necrosis Factor ""; ""2. Anti-TNF Mechanism of Action: Infliximab ""; ""3. Risk of Infections in the Use of Infliximab: Evidence""; ""4. Risk of Infection from the Use of Anti-TNF (Inflximab): Mechanisms Involved""; ""5. Other Risk Factors for Infection in Patients Treated with Infliximab ""; ""6. Infections ""; ""Bacterial Infections""
""Listeria """"Tuberculosis ""; ""Virus ""; ""Fungal Infections ""; ""Histoplasmosis ""; ""Coccidioidomycosis ""; ""Cryptococcosis ""; ""Aspergillosis ""; ""Candidiasis""; ""Pneumocystosis ""; ""7. Special Situations""; ""Perisurgical Infections ""; ""Hepatitis B Virus Infection ""; ""Hepatitis C Virus Infection ""; ""HIV Infection ""; ""Vaccines ""; ""Conclusions ""; ""References ""; ""Infliximab in Inflammatory Bowel Disease ""; ""Abstract ""; ""Pharmacology""; ""Uses ""; ""Inflammatory Crohn�s Disease ""; ""Fistulizing Crohn�s Disease ""; ""Ulcerative Colitis""; ""Mucosal Healing "" ""Pouchitis""""Extraintestinal Manifestations ""; ""Limitations ""; ""Predictors of Response to Infliximab ""; ""Infections ""; ""Malignancies and Lymphoma ""; ""Cutaneous, Neurological and Liver Manifestations ""; ""Congestive Heart Failure ""; ""Pregnancy ""; ""References ""; ""Infliximab: Up-to-Date on Indications and Warnings ""; ""Abstract ""; ""1. Introduction""; ""2. Pharmacology""; ""2.1. Structure and Mechanisms of Action""; ""2.2. Absorption ""; ""2.3. Distribution ""; ""2.4. Metabolism and Excretion ""; ""2.5. Dosage and Administration ""; ""2.6. Pharmacogenomics"" ""D) Chronic Eczema """"E) Hidradenitis Susppurativa (HS) ""; ""3.3. Other Verified Uses ""; ""a) SAPHO Syndrome ""; ""b) Kawasaki Disease ""; ""c) Pulmonary Fibrosis ""; ""d) Cap Polyposis ""; ""e) Postresuscitation Myocardial Dysfunction ""; ""f) B-Chronic Lymphocytic Leukemia ""; ""g) Diabetic Macular Edema ""; ""4. Warnings and Limitations""; ""4.1. Serious Infections ""; ""4.2. Malignancies ""; ""4.3. Hepatitis B virus Reactivation ""; ""4.4. Hepatotoxicity ""; ""4.5. Patients with Heart Failure ""; ""4.6. Hematological and Vascular Events ""; ""4.7. Hypersensitivity "" ""4.8. Neurological Events "" |
Record Nr. | UNINA-9910814402103321 |
New York, : Nova Science Publishers, c2012 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The influence of citrus liminoids on blood concentration of cholesterol and inflammatory responses in humans ... annual report |
Pubbl/distr/stampa | [Washington, D.C.], : U.S. Dept. of Agriculture, Agricultural Research Service |
Descrizione fisica | : HTML files |
Disciplina | 572 |
Soggetto topico |
Limonoids - Physiological effect
Inflammation Anti-inflammatory agents Blood lipids Cholesterol Biochemical markers |
Soggetto genere / forma | Periodicals. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910702930903321 |
[Washington, D.C.], : U.S. Dept. of Agriculture, Agricultural Research Service | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Marine Anti-inflammatory and Antioxidant Agents 2.0 / / edited by Donatella Degl'Innocenti and Marzia Vasarri |
Pubbl/distr/stampa | Basel : , : MDPI, , 2023 |
Descrizione fisica | 1 online resource (224 pages) |
Disciplina | 615.7 |
Soggetto topico | Anti-inflammatory agents |
ISBN | 3-0365-6785-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910683378003321 |
Basel : , : MDPI, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Mechanisms involved in the beneficial effects of blueberries on neuronal aging and behavior ... annual report |
Pubbl/distr/stampa | [Washington, D.C.], : U.S. Dept. of Agriculture, Agricultural Research Service |
Descrizione fisica | 1 online resource (4 volumes) |
Disciplina | 634.737 |
Soggetto topico |
Blueberries - Physiological effect
Blueberries - Health aspects Anti-inflammatory agents Nervous system - Degeneration - Nutritional aspects Brain - Aging - Prevention Aging - Nutritional aspects |
Soggetto genere / forma | Periodicals. |
ISSN | 2155-9732 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910702930503321 |
[Washington, D.C.], : U.S. Dept. of Agriculture, Agricultural Research Service | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Prospects for chemoprevention of colorectal neoplasia : emerging role of anti-inflammatory drugs / / Andrew T. Chan, Elmar Detering, editors |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | Berlin ; ; Heidelberg, : Springer, 2012, c2013 |
Descrizione fisica | 1 online resource (185 p.) |
Disciplina | 616.994347 |
Altri autori (Persone) |
ChanAndrew T
DeteringElmar |
Collana | Recent results in cancer research |
Soggetto topico |
Colon (Anatomy) - Cancer - Treatment
Anti-inflammatory agents |
ISBN |
1-283-63018-4
9786613942630 3-642-30331-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | What is chemoprevention today?- Mechanistic aspects in tumor development and progression of colorectal adenoma and carcinoma -- Mode of action of aspirin as a chemopreventive agent -- Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials -- COX-2 active agents in chemoprevention (includes aspirin, coxibs, and DFMO) -- New potential developments in aspirin/NSAID derivatives -- Aspirin in CRC chemoprevention in the context of other chronic diseases -- Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal adenoma and carcinoma -- Genetic risks for CRC and hereditary forms of CRC. – Strategies for prevention in high risk population. |
Record Nr. | UNINA-9910438134403321 |
Berlin ; ; Heidelberg, : Springer, 2012, c2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|